ArticleMethods in molecular biology (Clifton, N.J.)2026
Exploring the Chemotactic Effects of MIF on Neutrophils and T Cells and Methods for Selective Receptor Targeting.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Macrophage migration inhibitory factor (MIF) is a pleiotropic inflammatory cytokine and atypical chemokine that regulates both innate and adaptive immunity. Its broad expression and stress-induced release make MIF a key determinant of inflammation, cardiovascular diseases, and cancer. MIF acts as an upstream regulator within a complex ligand-receptor network comprising the more recently discovered MIF paralog, D-dopachrome tautomerase (D-DT, MIF-2), its cognate receptor CD74, and the chemokine receptors CXCR2, CXCR4, and ACKR3/CXCR7. MIF-driven effects, including leukocyte recruitment, cell migration, and inflammatory signaling, largely depend on the specific MIF receptor repertoire of the involved cell types, which can dynamically change in inflammatory settings. Here, we describe an optimized protocol for the ibidi 3D µ-Slide chemotaxis assay to study MIF-mediated pro-migratory effects on human neutrophils, a prototype of innate immune cells, and CD4
Indexed as
Identifiers
42129120What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.